Skip to main content
SpringerLink
Log in

Prise en charge de la récidive homolatérale d’un cancer du sein après traitement conservateur initial

  • Conference paper
Cancer du sein

  • 541 Accesses

Résumé

Ce chapitre porte sur la prise en charge diagnostique et thérapeutique d’une récidive intramammaire homolatérale isolée d’un cancer du sein ayant eu initialement un traitement conservateur. Il exclut la surveillance après traitement de la récidive locale. La récidive locale isolée homolatérale est définie comme une récidive intramammaire dans le sein traité (y compris avec atteinte de la peau par contiguïté ou nodule isolé sur la cicatrice initiale mais exclut les nodules de perméation et les récidives associées à une localisation ganglionnaire ou métastatique). La tumeur initiale et la récidive peuvent être un cancer in situ et/ ou invasif.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Sardanelli F, Boetes C, Borisch B et al. (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46: 1296–1316

    Article  PubMed  Google Scholar 

  2. El Khoury C, Tardivon A, Thibault F, Barreau B, Neuenschwander S (2007) How I perform a breast MRI J Radiol 88: 694–700

    Article  PubMed  Google Scholar 

  3. Taourel P, Xavier P, Boulet P, Lesnik A, Pujol J (2007) IRM du sein. IRM et suivi d’un cancer du sein. In: Taourel P, Xavier P, Boulet P, Lesnik A, Pujol J, eds. IRM du sein. Sauramps médical, Montpellier: 205–219

    Google Scholar 

  4. Ikeda DM, Hylton NM, Kinkel K et al. (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13: 889–895

    Article  PubMed  CAS  Google Scholar 

  5. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH (2009) Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer 115: 1363–1380

    Article  PubMed  Google Scholar 

  6. Dao TH, Rahmouni A, Campana F et al. (1993) Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187: 751–755

    PubMed  CAS  Google Scholar 

  7. Preda L, Villa G, Rizzo S et al. (2006) Magnetic resonance mammography in the evaluation of recurrence at the prior lympectomy site after conservative surgery and radiotherapy. Breast Cancer Reseach 8: R53

    Article  Google Scholar 

  8. Morakkabati N, Leutner CC, Schmiedel A, Schild HH, Kühl CK (2003) Breast MR imaging during or soon after radiation therapy. Radiology 229: 893–901

    Article  PubMed  Google Scholar 

  9. Abe H, Schmidt RA, Shah RN et al. (2010) MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 194: 370–377

    Article  PubMed  Google Scholar 

  10. Destounis S, Arieno A, Somerville PA et al. (2009) Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography. J Ultresound Med 28: 1337–1346

    Google Scholar 

  11. Malhaire C, El Khoury C, Thibault F et al. (2010) Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 20: 1554–1562

    Article  PubMed  CAS  Google Scholar 

  12. Saslow D, Boetes C, Burke W et al.; American Cancer Society Breast Cancer Advisory Group (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57: 75–89

    Article  PubMed  Google Scholar 

  13. Rieber A, Schirrmeister H, Gabelmann A et al. (2002) Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? Br J Radiol 75: 789–798

    PubMed  CAS  Google Scholar 

  14. Schelfout K, Van Goethem M, Kersschot E et al. (2004) Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30: 501–507

    PubMed  CAS  Google Scholar 

  15. Hollingsworth AB, Stough RG, O’Dell CA, Brekke CE (2008) Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 196: 389–397

    Article  PubMed  Google Scholar 

  16. Turnbull L, Brown S, Harvey I et al. (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 375: 563–571

    Article  PubMed  Google Scholar 

  17. Rajan R, Esteva FJ, Symmans WF (2004) Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response. Clin Breast Cancer 5: 235–238

    Article  PubMed  Google Scholar 

  18. Kennedy S, Merino MJ, Swain SM, Lippman ME (1990) The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol 21: 192–198

    Article  PubMed  CAS  Google Scholar 

  19. Moore GH, Schiller JE, Moore GK (2004) Radiation-induced histopathologic changes of the breast: the effects of time. Am J Surg Pathol 28: 47–53

    Article  PubMed  Google Scholar 

  20. Bijker N, Meijnen P, Peterse JL et al. (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24: 3381–3387

    Article  PubMed  Google Scholar 

  21. Bijker N, Peterse JL, Duchateau L et al. (2001) Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 84: 539–544

    Article  PubMed  CAS  Google Scholar 

  22. Idvall I, Ringberg A, Anderson H, Akerman M, Fernö M (2005) Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours. Breast 14: 290–297

    Article  PubMed  Google Scholar 

  23. Mann GB, Fahey VD, Feleppa F, Buchanan MR (2005) Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol 23: 5148–5154

    Article  PubMed  Google Scholar 

  24. Cahill RA, Walsh D, Landers RJ, Watson RG (2006) Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy. Ann Surg Oncol 13: 45–51

    Article  PubMed  Google Scholar 

  25. Burge CN, Chang HR, Apple SK (2006) Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? Breast 15: 167–172

    Article  PubMed  Google Scholar 

  26. Usami S, Moriya T, Amari M et al. (2007) Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol 37: 250–255

    Article  PubMed  Google Scholar 

  27. Arnedos M, Nerurkar A, Osin P, A’Hern R, Smith IE, Dowsett M (2009) Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 20: 1948–1952

    Article  PubMed  CAS  Google Scholar 

  28. Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22: 1151–1159

    Article  PubMed  CAS  Google Scholar 

  29. Idirisinghe PK, Thike AA, Cheok PY et al. (2010) Hormone receptor and C-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol 133: 416–429

    Article  PubMed  Google Scholar 

  30. Liedtke C, Broglio K, Moulder S et al. (2009) Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Ann Oncol 20: 1953–1958

    Article  PubMed  CAS  Google Scholar 

  31. Fourquet A, Campana F, Zafrani B et al. (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719–725

    Article  PubMed  CAS  Google Scholar 

  32. Touboul E, Buffat L, Belkacemi Y et al. (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43: 25–38

    Article  PubMed  CAS  Google Scholar 

  33. Voogd AC, Tienhoven GV, Peterse HL et al. (1999) Local recurrence after breast conservation therapy for early stage breast carcinoma. Detection, treatment, and outcome in 266 patients. Cancer 85: 437–446

    Article  PubMed  CAS  Google Scholar 

  34. Van Oost FJ, van der Hoeven JJM, Hoekstra OS et al. (2004) Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography. Eur J Cancer 40: 1545–1553

    Article  PubMed  Google Scholar 

  35. Tennant S, Evans A, Macmillan D et al. (2009) CT staging of loco-regional breast cancer recurrence. A worthwhile practice? Clin Radiol 64: 885–890

    Article  PubMed  CAS  Google Scholar 

  36. Hodgson NC, Gulenchyn KY (2008) Is there a role for Positron Emission Tomography in breast cancer staging? J Clin Oncol 26: 712–720

    Article  PubMed  Google Scholar 

  37. Schmidt GP, Baur-Melnyk AB, Haug A et al. (2008) Comprehensive imaging of tumor recurrence in breast cancer patient using whole body MRI at 1,5 and 3T compared with FDG-PET-CT. Eur J Radiol 65: 47–58

    Article  PubMed  Google Scholar 

  38. Kurtz JM, Amalric R, Brandone H et al. (1988) Results of salvage surgery for mammary recurrence following breast-conserving therapy. Ann Surg 207: 347–351

    Article  PubMed  CAS  Google Scholar 

  39. Salvadori B, Marubini E, Miceli R et al. (1999) Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg 86: 84–87

    Article  PubMed  CAS  Google Scholar 

  40. Fowble B, Solin LJ, Schultz DJ et al. (1990) Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19: 833–842

    Article  PubMed  CAS  Google Scholar 

  41. Osborne MP, Borgen PI, Wong GY, Rosen PP, McCormick B (1992) Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy. Surg Gynecol Obstet 174: 189–194

    PubMed  CAS  Google Scholar 

  42. Cajucoum CC, Tsangaris TH, Nemoto T et al. (1993) Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer 71: 1774–1779

    Article  Google Scholar 

  43. Abner AL, Recht A, Eberlein T et al. (1993) Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 11: 44–48

    PubMed  CAS  Google Scholar 

  44. Voogd AC, van Tienhoven G, Peterse HL et al. for the Dutch Study Group on Local Recurrence after Breast Conservation (1999) Local recurrence after breast conservation therapy for early stage breast carcinoma: Detection, treatment, and outcome in 266 patients. Cancer 85: 437–446

    Article  PubMed  CAS  Google Scholar 

  45. Doyle T, Schultz DJ, Peters C et al. (2001) Long-term results of local recurrences after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 51: 74–80

    Article  PubMed  CAS  Google Scholar 

  46. Huang E, Buchholz TA, Meric F et al. (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95: 2059–2067

    Article  PubMed  Google Scholar 

  47. Alpert TE, Kuerer HM, Arthur DW et al. (2005) Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 63: 845–851

    Article  PubMed  Google Scholar 

  48. Borner M, Bacchi M, Goldhirsch A et al. (1994) First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 12: 2071–2077

    PubMed  CAS  Google Scholar 

  49. Hannoun-Levi JM, Raoust I (2008) In regard to Wahl et al. Int J Radiat Oncol Biol Phys 70: 477–484

    Article  Google Scholar 

  50. Richards GM, Tomé WA, Robins HI et al. (2009) Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Res Treat 114: 307–313

    Article  PubMed  Google Scholar 

  51. Kurtz JM, Amalric R, Brandone H et al. (1989) Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 63: 1912–1917

    Article  PubMed  CAS  Google Scholar 

  52. Gentium O, Botteri E, Rotmensz N et al. (2007) When can a second conservative approach be considered for ipsilateral breast tumor recurrence? Ann Oncol 18: 468–472

    Google Scholar 

  53. Anderson SJ, Wapnir I, Dignam JJ et al. (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27: 2466–2473

    Article  PubMed  Google Scholar 

  54. Dalberg K, Liedberg A, Johansson U et al. (2003) Uncontrolled local disease after salvage treatment for ipsilateral breast tumor recurrence. Eur J Surg Oncol 29: 143–154

    PubMed  Google Scholar 

  55. Kurtz JM, Jacquemier J, Amalric R et al. (1991) Is breast conservation after local recurrence feasible? Eur J Cancer 27: 240–244

    Article  PubMed  CAS  Google Scholar 

  56. Dalberg D, Mattsson A, Sandelin K et al. (1998) Outcome of treatment for ipsilateral breast tumor recurrence in early stage breast cancer. Breast Cancer Res Treat 49: 69–78

    Article  PubMed  CAS  Google Scholar 

  57. Komoike Y, Akiyama F, Lino Y et al. (2005) Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12: 104–111

    Article  PubMed  Google Scholar 

  58. Chen SL, Martinez SR (2008) The impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg 196: 495–499

    Article  PubMed  Google Scholar 

  59. Botteri E, Romensz N, Sangalli C et al. (2009) Unavoidable mastectomy for ipsilateral breast tumor recurrence after conservative surgery: patient outcome. Ann Oncol 20: 1008–1012

    Article  PubMed  CAS  Google Scholar 

  60. Hannoun-Levi JM, Houvenaeghel G, Ellis S et al. (2004) Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys 60: 1385–1392

    Article  PubMed  Google Scholar 

  61. Guix B, Lejárcegui JA, Tello JI et al. (2010) Exeresis and Brachytherapy as Salvage Treatment for Local Recurrence After Conservative Treatment for Breast Cancer: Results of a Ten-Year Pilot Study. Int J Radiat Oncol Biol Phys 78: 804–810

    Article  PubMed  Google Scholar 

  62. Maulard C, Housset M, Brunei P et al. (1995) Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol 18: 348–352

    Article  PubMed  CAS  Google Scholar 

  63. Deutsch M (2002) Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53: 687–691

    Article  PubMed  Google Scholar 

  64. Chadha M, Feldman S, Boolbol S, Wang L, Harrison LB (2008) The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Brachytherapy 7: 22–28

    Article  PubMed  Google Scholar 

  65. Trombetta M, Julian T, Bhandari T et al. (2008) Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience. Brachytherapy 7: 29–36

    Article  PubMed  Google Scholar 

  66. Trombetta, M., T.B. Julian, D.E. Werts, W McWilliams, Y. Kim, M. Miften et al., Longterm cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Am J Clin Oncol. 2009;32:314–318

    Article  PubMed  Google Scholar 

  67. Hannoun-Levi JM, Castelli J, Plesu A, Courdi A, Raoust I, Lallement M, Flipo B, Ettore F, Chapelier C, Follana P, Ferrero JM, Figl A; Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction; Brachytherapy 2010.

    Google Scholar 

  68. Pinski RW, Rebner M, Pierce LJ et al. (2007) Recurrent cancer after breast-conserving surgery with radiation therapy for DCIS: mammographic features, method of detection, and stage of recurrence. Am J Surg Oncol 189: 140–144

    Google Scholar 

  69. Solin LJ, Fourquet A, Vicini FA et al. (2001) Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected DCIS of the breast. Cancer 91: 1090–1097

    Article  PubMed  CAS  Google Scholar 

  70. Cox CE, Furman BT, Kiluk JV et al. (2008) Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg 207: 57–61

    Article  PubMed  Google Scholar 

  71. Intra M, Trifiro G, Galimberti V et al. (2007) Second axillary sentinel node biopsy for ipsilateral breast tumor recurrence. Br J Surg 94: 1216–1219

    Article  PubMed  CAS  Google Scholar 

  72. Schrenck P, Tausch C, Wayand W (2008) Lymphating mapping in patients with primary or recurrent breast cancer following previous axillary surgery. Eur J Surg Oncol 34: 851–856

    Google Scholar 

  73. Port ER, Garcia-Etienne CA, Park J et al. (2007) Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14: 2209–2214

    Article  PubMed  Google Scholar 

  74. Palit G, Jacquemyn Y, Tjalma W (2008) Sentinel node biopsy for ipsilateral breast cancer recurrence: a review. Eur J Gynaecol Oncol 29: 565–567

    PubMed  CAS  Google Scholar 

  75. Koizumi M, Koyama M, Tada K et al. (2008) The feasibility of sentinel node biopsy in the previous treated breast. Eur J Surg Oncol 34: 365–368

    PubMed  CAS  Google Scholar 

  76. Tasevski R, Gogos AJ, Mann GB (2009) Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse. Breast 18: 322–326

    Article  PubMed  CAS  Google Scholar 

  77. Kaur P, Kiluk JV, Meade T et al. (2011) Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection. Ann Surg Oncol 18: 727–732

    Article  PubMed  Google Scholar 

  78. Halverson KJ, Perez CA, Kuske RR et al. (1992) Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 23: 285–291

    Article  PubMed  CAS  Google Scholar 

  79. Willner J, Kiricuta IC, Kolbl O (1997) Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 37: 853–863

    Article  PubMed  CAS  Google Scholar 

  80. Hsi RA, Anteil A, Schultz DJ, Solin LJ (1998) Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients. Int J Radiat Oncol Biol Phys 42: 495–499

    Article  PubMed  CAS  Google Scholar 

  81. Waeber M, Castiglione-Gertsch M, Dietrich D et al. (2003) Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 14: 1215–1221

    Article  PubMed  CAS  Google Scholar 

  82. Fisher B, Anderson S, Fisher ER et al. (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338: 327–331

    Article  PubMed  CAS  Google Scholar 

  83. Wapnir IL, Anderson SJ, Mamounas EP et al. (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24: 2028–2037

    Article  PubMed  Google Scholar 

  84. Whelan T, Clark R, Roberts R et al. (1994) Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 30: 11–16

    Article  PubMed  CAS  Google Scholar 

  85. Clark RM, Whelan T, Levine M et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88: 1659–1664

    Article  PubMed  CAS  Google Scholar 

  86. Moran MS, Haffty BG (2002) Local-regional breast cancer recurrence: Prognostic groups based on patterns of failure. Breast J 8: 81–87

    Article  PubMed  Google Scholar 

  87. Komoike Y, Akiyana F, Lino Y et al. (2006) Ipsilateral breast tumor recurrence (IBTR) after breast conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106: 35–41

    Article  PubMed  Google Scholar 

  88. van der Sangen MJ, van de Poll-Franse LV, Roumen RM et al. (2006) The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 32: 34–38

    PubMed  Google Scholar 

  89. Haffty BG, Reiss M, Beinfield M et al. (1996) Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 14: 52–57

    PubMed  CAS  Google Scholar 

  90. Stotter A, Atkinson EN, Fairston BA et al. (1990) Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 212: 166–1672

    Article  PubMed  CAS  Google Scholar 

  91. Janjan NA, McNeese MD, Buzdar AU, Montague ED, Oswald MJ (1986) Management of locoregional recurrent breast cancer. Cancer 58: 1552–1556

    Article  PubMed  CAS  Google Scholar 

  92. Olson CE, Ansfield FJ, Richards MJ et al. (1977) Review of local soft tissue recurrence of breast cancer irradiated with and without actinomycin-D. Cancer 39: 1981–1983

    Article  PubMed  CAS  Google Scholar 

  93. Buzdar AU, Blumenschein GR, Smith TL et al. (1979) Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED). J Surg Oncol 12: 27–40

    Article  PubMed  CAS  Google Scholar 

  94. Fentiman IS, Balkwill FR, Cuzick J et al. (1987) A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence. Eur J Surg Oncol 13: 425–428

    PubMed  CAS  Google Scholar 

  95. Halverson KJ, Perez CA, Kuske RR et al. (1992) Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 15: 93–101

    Article  PubMed  CAS  Google Scholar 

  96. Rauschecker H, Clarke M, Gatzemeier W et al. (2007) Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev CD002195

    Google Scholar 

  97. Wapnir IL, Aebi S, Gelber S et al. (2008) Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer. Ann Surg Oncol 15: 3227–3231

    Article  PubMed  Google Scholar 

  98. Casalini P, Carcangiu ML, Tammi R et al. (2008) Two distinct local relapse subtypes in invasive breast cancer: effect of their prognostic impact. Clin Cancer Res 14: 25–31

    Article  PubMed  CAS  Google Scholar 

  99. Kamby C, Sengelov L (1997) Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res Treat 45: 181–192

    Article  PubMed  CAS  Google Scholar 

  100. Smith TE, Lee D, Turner BC et al. (2000) True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48: 1281–1289

    Article  PubMed  CAS  Google Scholar 

  101. Nishimura S, Takahashi K, Akiyama F et al. (2005) Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer 12: 112–117

    Article  PubMed  Google Scholar 

  102. Yoshida T, Takei H, Kurosumi M et al. (2010) True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment. Breast J 16: 127–133

    Article  PubMed  Google Scholar 

  103. Gujral DM, Sumo G, Owen JR et al. (2011) Ipsilateral Breast Tumor Relapse: Local Recurrence Versus New Primary Tumor and the Effect of Whole-Breast Radiotherapy on the Rate of New Primaries. Int J Radiat Oncol Biol Phys 79: 19–25

    Article  PubMed  Google Scholar 

  104. Bollet MA, Servant N, Neuvial P et al. (2008) High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. J Natl Cancer Inst 100: 48–58

    Article  PubMed  CAS  Google Scholar 

  105. Vicini FA, Antonucci JV, Goldstein N et al. (2007) The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer 109: 1264–1272

    Article  PubMed  Google Scholar 

  106. Goldstein NS, Vicini FA, Hunter S et al. (2005) Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol 123: 679–689

    Article  PubMed  Google Scholar 

  107. McGrath S, Antonucci J, Goldstein N et al. (2010) Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am J Clin Oncol 33: 17–22

    Article  PubMed  CAS  Google Scholar 

  108. Panet-Raymond V, Truong PT, Watson PH (2010) Ipsilateral breast tumor recurrence after breast-conserving therapy. Expert Rev Anticancer Ther 10: 1229–1238

    Article  PubMed  Google Scholar 

Download references

Authors
  1. B. Barreau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Ettore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Giard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.-M. Hannoun-Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Kerrou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Tredan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Barreau, B., Ettore, F., Giard, S., Hannoun-Levi, JM., Kerrou, K., Tredan, O. (2012). Prise en charge de la récidive homolatérale d’un cancer du sein après traitement conservateur initial. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0245-9_11

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0244-2

  • Online ISBN: 978-2-8178-0245-9

Publish with us

Policies and ethics

Search

Navigation